Sort by
Refine Your Search
-
Listed
-
Field
-
supported by multiple NIH R01 grants and focuses on molecular immunology and inflammatory mechanisms. Cutting-edge research models (eg. primary cell/organoid cultures, mouse models and human clinical samples
-
proteins on brain circuits controlling puberty and fertility are a key focus. Research is conducted in mouse models, addressing the interaction of hormones and neuropeptides in coordinating the brain’s
-
of Emmanuel Katsanis, MD to pursue studies in transplant and tumor immunology. Research involves murine bone marrow and peripheral blood stem cell transplantation and tumor models. Studies may also include use
-
patient-specific human induced pluripotent stem cells (iPSCs), primary human cells/tissues, along with animal models, to develop a platform for the evaluation of cardiovascular toxicity associated with
-
use a combination of patient-specific human induced pluripotent stem cells (iPSCs), primary human cells/tissues, along with animal models, to develop a platform for the evaluation of cardiovascular
-
models, human tissue and blood samples. Use biochemical, cellular, molecular, and pharmacological approaches to for mechanistic studies. Use cutting-edge technologies for transcriptomic, proteomic, and
-
homeostasis. Using mouse models, histology, cell culture, differential expression analyses, and molecular biology assays, our lab studies the molecular mechanisms that regulate metabolic processes and iron
-
lung injury to both neonatal and adult lung using rodent models and in vitro cell culture techniques. Allergen based asthma models are also being studied. Pathobiological aspect involves investigating
-
://phoenixmed.arizona.edu/ Location Greater Phoenix Area Address Phoenix, AZ USA Position Highlights The Dr. Kalin lab is recruiting a motivated postdoctoral fellow to study molecular mechanisms involved in tissue injury
-
researcher with a strong background in cell and molecular biology of cancer and cancer therapeutics/drug discovery development. This project will be defining targets of therapy in a variety of human and murine